New Products: GeneDx's Mito101

Premium

GeneDx has launched Mito101, a sequencing-based diagnostic that targets 101 nuclear genes associated with mitochondrial disorders. The test expands on the company's current Mito24 test, which targets just 24 genes.

Mito101 targets 1,000 exons from 101 genes and disease-associated variants are verified with Sanger sequencing. It has a turnaround time of around 10 weeks and a contract price of $6,500.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.